To verify the reliability and reproducibility of the CRISPR KO data on NAT essentiality, we also examined an independent genome-wide CRISPR screen performed on 14 acute myeloid leukemia (AML) cell lines [28] (Figure 4E,F). Here, BRD2 is linked to acute myeloid leukemia.